I have done alot of research over the past week on Living Cell Technology and what I have found is almost paradoxical.
With new leadership in place, funding secured and the company in the midst of phase II clinical trials of its flagship product for treating Type I Diabetes, DIABECELL, I am quite baffled as to why the SP of LCT is at a 52 week low. Especially when you also consider its other product in the pipeline, NTCELL, which is targeting diseases such as Parkinson?s disease, Huntington?s disease, stroke and hearing loss.
At a SP of 12 cents, this one is definitely flying under the radar if you ask me.
- Forums
- ASX - By Stock
- the living cell technology paradox
I have done alot of research over the past week on Living Cell...
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
-0.001(9.09%) |
Mkt cap ! $16.87M |
Open | High | Low | Value | Volume |
1.0¢ | 1.0¢ | 1.0¢ | $500 | 50K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 3533429 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 1744396 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 3533429 | 0.010 |
6 | 6046120 | 0.009 |
7 | 1447959 | 0.008 |
7 | 6280009 | 0.007 |
6 | 2493750 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 1744396 | 12 |
0.012 | 871219 | 5 |
0.013 | 854768 | 3 |
0.014 | 668331 | 4 |
0.015 | 882495 | 5 |
Last trade - 13.34pm 28/06/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online